New US charity to foster drug research sparks fears of undue industry influenceBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39405.716667.DB (Published 22 November 2007) Cite this as: BMJ 2007;335:1069
- Bob Roehr
A new charitable foundation that was set up to promote collaboration in research between the US Food and Drug Administration and the drug and medical device industries has sparked concerns that it will undermine the FDA's independence.
The Reagan-Udall Foundation, which will be headed by Mark McClellan, who at one time led the Food and Drug Administration and later the federal Medicare and Medicaid health insurance programmes, was spearheaded by the Democrat senator Ted Kennedy in a bid to reform the FDA.
The foundation's creation should shorten the time it takes to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial